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Abstract
Purpose: With the move towards magnetic resonance imaging (MRI) as a primary
treatment planning modality option for men with prostate cancer, it becomes critical to quantify the potential uncertainties introduced for MR‐only planning. This
work characterized geometric and dosimetric intra‐fractional changes between the
prostate, seminal vesicles (SVs), and organs at risk (OARs) in response to bladder
ﬁlling conditions.
Materials and methods: T2‐weighted and mDixon sequences (3–4 time points/subject, at 1, 1.5 and 3.0 T with totally 34 evaluable time points) were acquired in nine
subjects using a ﬁxed bladder ﬁlling protocol (bladder void, 20 oz water consumed
pre‐imaging, 10 oz mid‐session). Using mDixon images, Magnetic Resonance for Calculating Attenuation (MR‐CAT) synthetic computed tomography (CT) images were
generated by classifying voxels as muscle, adipose, spongy, and compact bone and by
assignment of bulk Hounsﬁeld Unit values. Organs including the prostate, SVs, bladder, and rectum were delineated on the T2 images at each time point by one physician. The displacement of the prostate and SVs was assessed based on the shift of
the center of mass of the delineated organs from the reference state (fullest bladder).
Changes in dose plans at different bladder states were assessed based on volumetric
modulated arc radiotherapy (VMAT) plans generated for the reference state.
Results: Bladder volume reduction of 70 ± 14% from the ﬁnal to initial time point
(relative to the ﬁnal volume) was observed in the subject population. In the empty
bladder condition, the dose delivered to 95% of the planning target volume (PTV)
(D95%) reduced signiﬁcantly for all cases (11.53 ± 6.00%) likely due to anterior
shifts of prostate/SVs relative to full bladder conditions. D15% to the bladder
increased consistently in all subjects (42.27 ± 40.52%). Changes in D15% to the rectum were patient‐speciﬁc, ranging from −23.93% to 22.28% (−0.76 ± 15.30%).
Conclusions: Variations in the bladder and rectal volume can signiﬁcantly dislocate
the prostate and OARs, which can negatively impact the dose delivered to these
organs. This warrants proper preparation of patients during treatment and imaging
sessions, especially when imaging required longer scan times such as MR protocols.

---------------------------------------------------------------------------------------------------------------------------------------------------------------------This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2019 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine
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1 | INTRODUCTION

physiological status that may confound accurate dosimetry and high‐
precision radiation therapy. One of the main issues that arises with

Prostate cancer is the most common type of cancer in men, with

MRI is the longer scanning times as compared to CT, which may lead

over 160 000 cases reported in 2017 in the United States.1 The cur-

to higher variations in the bladder and rectal volumes. It is currently

rent treatment‐planning workﬂow involves using computed tomogra-

unknown how robust MR‐only treatment planning is to internal anat-

phy simulation (CT‐SIM) as the primary planning modality. However,

omy changes nor how the dosimetry may be impacted. This work

magnetic resonance imaging (MRI) has been shown to show superior

characterizes the temporal, spatial, and dosimetric intra‐fractional

accuracy to CT for identifying the prostate gland, the prostatic apex,

changes between the prostate, seminal vesicles (SVs), and other

and areas of high tumor burden.2–6 By performing an MRI to CT

organs at risk (OARs) in response to bladder ﬁlling conditions for

rigid registration, the prostate can be delineated on MRI and then

MR‐only prostate cancer radiation therapy planning.

transferred to CT for subsequent planning. This co‐registration may
introduce uncertainties of 2–3 mm for prostate cancer.7–9 Recently,

2 | MATERIALS AND METHODS

as a means to circumvent this uncertainty and streamline the clinical
workﬂow, MR‐only planning has emerged in the clinic. For the male
pelvis, two MR‐only packages are currently clinically available for

2.A | Subjects and bladder ﬁlling protocol

prostate cancer treatment planning with synthetic CTs [synCTs, or

Nine healthy male volunteers (Age: 43 ± 10.1 yr (range: 25–61 yr);

CTs generated from MRI input(s)]. One FDA‐approved software

Weight: 78.8 ± 9.6 kg) were recruited and consented to being

package, the Philips Magnetic Resonance for Calculating Attenuation

scanned at one of the three different magnetic ﬁeld strengths (1.0, 1.5

(MR‐CAT), is based on a dual echo three‐dimensional (3D) mDixon

or 3.0 T). Three volunteers were scanned using a large, rigid 8‐element

fast ﬁeld echo sequence with synCTs generated on the scanner.10,11

phased array coil on a 1.0 T Panorama High Field Open Magnetic Res-

12

pelvic MR‐CAT images of 23

onance System (Philips Medical Systems, Cleveland, OH) equipped

patients with prostate cancer underwent deformable registration to

with ﬂat table‐top (Civco, Orange City, IA) and external laser system as

the planning CT images and found good overall agreement over the

described previously.21 Three other healthy male volunteers were

entire pelvis volume [mean absolute error (MAE) values of

scanned at 1.5 T (Philips Achieva with 32‐element torso coil), and the

65 ± 5 HU] with even smaller difference observed in the fat and

last three on a 3.0 T (Philips Ingenia with integrated posterior 32‐ele-

muscle (~40 HU) across all subjects. However, it is not currently

ment coil and anterior array) scanner with standard concave table‐

known how synthetic CT generation performs over a variety of

tops. Pelvic MR images were acquired according to a bladder ﬁlling

internal conditions nor has the dosimetric impact of this been char-

protocol with the patient in a supine position (Fig. 1). Prior to imaging,

acterized. The other MR‐only package (Spectronic's MriPlanner) is

each subject voided their bladder and consumed 20 oz of water. The

regulatory approved (CE‐marked), and creates synCT images based

ﬁrst acquisition represented an empty bladder state. An additional 10–

on a statistical decomposition algorithm (SDA) from a single T2‐

20 oz of water was consumed without subject repositioning before 1–

In a recent study by Farjam et al.,

weighted dataset.13 Comparison of the synCT and CT‐based dose

2 intermediate states were acquired, and a ﬁnal full bladder acquisition

plans for prostate showed <1% difference in the mean absorbed

was performed. Due to longer scan times at low magnetic ﬁelds for

dose to the PTV for the MR‐CAT14 and 0.0 ± 0.2% for the SDA

1 T experiments, imaging was possible at only three time points during

13

the ~45 min imaging session; but at 1.5 and 3 T, shorter acquisition

methods.

It has been shown that substantial variations in the bladder volume occur during the course of treatment.

15,16

Importantly, the

variations in the bladder ﬁlling adversely impact the dose delivered

times allowed image acquisition at three to four time points for each
subject. Overall, a total of 34 evaluable time points were analyzed for
the entire cohort.

to the prostate over a standard course of radiotherapy for the
prostate.17,18 Huang et al.19 used daily cone‐beam computer tomog-

2.B | Imaging protocol

raphy (CBCT) images to measure target/organ volumes and dosimetric differences in 28 prostate cancer patients and found mean

T2‐weighted turbo spin echo images were acquired since it is the

percentage volume differences of 44% within the bladder volumes

most commonly used image for delineation of organs in the pelvis.22

in the treatment plan which led to percentage dose difference of

The imaging protocol also consisted of dual echo 3D FFE (Fast Field

2 ± 2% in the prostate.

Echo) mDIXON sequences11 which were optimized for acquisition at

As MRI emerges as a primary treatment planning modality option
20

for prostate cancer,

it becomes important to quantify the potential

uncertainties introduced in an MR‐only workﬂow due to variable

each ﬁeld strength (3T: TR/TE1/TE2 = 3.83/1.23/2.4 ms, Voxel Size =
1.45 × 1.45 × 0.23 mm,

BW = 1072 Hz;

1.5 T:

TR/TE1/TE2 = 6/

1.78/4 ms, Voxel Size = 1.45 × 1.45 × 0.28 mm, BW=541 Hz; 1 T:

12
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F I G . 1 . Bladder ﬁlling protocol. The
highlighted planning target volume (PTV)
can be seen based on the delineation of
the prostate at the last time point. Effects
of changes in the bladder volume can be
seen in earlier time points where the shift
of the prostate leads the PTV contour to
overlap with the rectum as the bladder
gets smaller in volume.

TR/TE1/TE2 = 15.87/6.9/13.81 ms, Voxel Size = 1.41 × 1.41 × 0.74

SVs (proxSVs) and the planning target volume (PTV) consisting of

mm, BW = 975 Hz). The mDixon scan is designed to yield high‐geo-

the prostate and proxSVs with a 1 cm expansion in all directions

metric accuracy by using short echo times and high bandwidth. The

except posteriorly, which was expanded 0.6 cm. Overall, 170 evalu-

advantage of using the two echoes in the mDIXON approach is to

able contours were delineated in this study. For each volunteer, ini-

allow water, fat, and in‐phase images to be derived within the same

tial and intermediate T2‐weighted images of each subject and their

acquisition by using the frequency shift of the fat and water pro-

corresponding contours were rigidly registered to the T2‐weighted

tons.11 These images are inputted into the MR‐CAT software to pro-

image of the ﬁnal time point (image with the largest bladder volume)

duce the Synthetic CT image used for treatment planning.10 Brieﬂy,

using three parameter translation with mutual information as the

MR‐CAT automatically segments the external anatomy from back-

cost function and nearest neighbor interpolation in FSL (FMRIB Soft-

ground air using the water and in‐phase images. Next, a model‐based

ware Library, Wellcome Center, Oxford, UK). This step ensured

segmentation method is used to segment bone from the external

matching of the bony structures as the ﬁxed components of the

contour based on training datasets.11 Soft tissue is deﬁned as voxels

images across different time points as well as isolation of local

10,11,23

within the body volume and outside the segmented bone.

An

intensity‐based classiﬁcation is then used to segment adipose and

effects such as possible movement (displacement) during the imaging
period.

muscle within the soft tissue using the water and fat images. Finally,

Next, for each time point, the contours of each organ were con-

the bone voxels are divided into compact and spongy bone based on

verted into a solid three‐dimensional volume using MATLAB

the voxel intensity of the in‐phase image. In summary, MR‐CAT cate-

(MATLAB R2016b, The MathWorks, Inc., Natick, MA, USA). The cen-

gorizes the contents of the MR images into ﬁve classes (air, fat,

ter of mass (COM) coordinates for each organ was calculated by

water‐rich tissue, spongy bone, and compact bone) and assigns to

ﬁnding the mean coordinates of all voxels of the volume along each

each voxel a bulk Hounsﬁeld Unit value based on its classiﬁcation,

major axis. The displacement of each organ was deﬁned as the COM

and the ﬁnal synCT image is generated for treatment planning.

shift relative to the ﬁnal time point.

11

One current limitation of MR‐CAT is that it does not account for
rectal gas in the image classiﬁcation. To fully elucidate the dosimetric
impact of bladder and rectal status changes, the intestinal gas

2.D | Dosimetric analysis

with each rectal contour was automatically thresholded and

Using MR‐CAT images of the last time point (i.e., full bladder, which

assigned a CT value of −350 HU based on values obtained from the

is consistent with our clinical practice), volumetric modulated arc

literature.24

radiotherapy (VMAT) plans were generated using two full arc beams
with 6 MV photons. The treatment planning was designed to deliver

2.C | Volumetric and geometric analysis

79.2 Gy to the PTV using RTOG 0815 dose constraints as a guideline.25 Next, plans were copied and recalculated to the synCTs of

The prostate, SVs, bladder, and rectum were delineated on the T2‐

the other time points using ﬁxed monitor units from the full bladder

weighted images by a single physician in the Eclipse Treatment Plan-

plans. After all the plans were created for each subject, an auto-

ning System (Version 11.0,Varian Medical Systems, Palo Alto, CA).

mated MATLAB program parsed the dose volume histograms (DVHs)

Boolean operations were used to generate the proximal 1 cm of the

in Eclipse and dosimetric data were tabulated for several dose

NEJAD‐DAVARANI
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metrics for the PTV and OARs according to QUANTEC recom-

had >2 mm vector displacement, primarily in A‐P direction (range:

mended endpoints.26–28

5.2 mm posterior to 7.8 mm anterior), with 7 of the 9 cases shifting
in the anterior direction. In one subject, the S‐I displacement was

2.E | Statistical analysis

dominant with 5.43 mm inferior shift. For the SVs, a strong association was observed between the displacement in the A‐P direction

Repeated measures mixed models containing ﬁxed (time points) and

and the rectal volume changes, but no signiﬁcant association was

random (subjects) effects were used to assess the signiﬁcance of

found with the bladder volume changes with either cardinal direc-

changes of dose at different bladder states (initial, middle, and ﬁnal)

tion. The same results were also found when both the changes in

while using the multiple/repeated measures on the same subject. If

bladder and rectum were considered in the same model. Physician

the effect of the bladder states was signiﬁcant (P < 0.05), pairwise

delineations on the T2‐weighted images revealed that the overall

comparisons of three time points using the overall mean square error

prostate volume change was 1.0% ± 5.5% [range: (−6.4%, 10.3%)]

(MSE) was calculated.

between the empty and full bladder states.

To investigate the associations between organ displacement and

Additional analyses were done to test whether the centroids for

bladder and rectum volumes, multilevel modeling methods29 were

prostate and SVs change in the same way for changes in bladder

used with the intercept coefﬁcient as the random effect and the

and rectum volumes. For the changes in bladder and rectal volume,

slopes (effect of changes of the bladder/rectum) as the ﬁxed effect.

there was no signiﬁcant difference observed between displacements

Analysis was done both by considering the bladder and rectum

in the Left–Right (L‐R) direction for prostate and SVs (P = 0.954 and

volumes separately as well as in the same model. The testing level

P = 0.072, respectively). However, the differences between displace-

of signiﬁcance was set at 0.05. All analyses were done using SAS

ments in the SI and AP directions for prostate and SVs were signiﬁ-

version 9.4.

cant (P = 0.0015 and P = 0.008, respectively, for changes in bladder
volume and P = 0.028 and P = 0.028 for changes in the rectum

3 | RESULTS

volume).

3.A | Volumetric and geometric analysis

3.B | Dosimetric analysis

Subjects had an average bladder volume increase of 342.4 ± 284%

Figure 3 highlights synthetic CTs for subjects 2 and 5 and their cor-

between initial and ﬁnal time points (137.26 ± 113.12 cc to

responding treatment plans that were optimized at the full bladder

417.2 ± 262.1 cc) and the corresponding change in rectal volume

state and applied to the empty bladder geometry. Subject 2 had the

was ‐6.9 ± 37.7% (102.8 ± 77.2 cc to 102.3 ± 57.9 cc). Figure 2

highest percent increase of the rectal volume (52% or 71.5 cc) along

shows the 3D rendered volumes of the prostate and OARs for sub-

with 56% increase in the bladder volume (125 cc) between the two

jects 3 (largest rectal volume) and 7 (largest bladder volume), who

time points. The prostate shifted posteriorly between the full to

also had the largest prostate vector displacements of ~6 mm. The

empty state due to the change in bladder and rectal volumes. DVH

dominant directions of the shift of the prostate between the bladder

analysis revealed a 20.2% reduction in the D95% dose to the PTV

states were in the A‐P direction in both subjects. With reference to

and 22% increase of the D15% dose to the bladder (D15%(TP1) =

the COM coordinates of the prostate at the ﬁnal time point, the A‐P

80.13 Gy) which is deemed not clinically acceptable.28 However,

movement of the prostate in subject 3 showed 5.92 and 5.61 mm

the mean dose to the rectum decreased by 11.98% (D15% (TP1) =

displacement (anteriorly) at the second and ﬁrst time points. The
prostate displacement in subject 7 was 7.75 and 5.81 mm (posteriorly) in these two time points.

2.3 Gy).
Table 2 lists the minimum dose and D95% to the PTV as well as
the D15%, D25%, and D35% to the bladder and rectum, as mea-

Table 1 summarizes the statistics for the displacement of the

sured using the DVH of each of the nine subjects at the bladder full

prostate and SVs between the full and empty bladder states. The

and bladder empty states. The tables show that the dose delivered

prostate had a dominant vector displacement in the Anterior–Poste-

to the PTV is reduced in every subject between the bladder full and

rior (A‐P) direction, ranging from 1.3 to 5.6 mm across all subjects.

bladder empty states and the dose delivered to the bladder is

Five of the nine subjects had a prostate displacement of higher than

increased. Statistical analysis of the dose to the PTV shows that

2 mm along the A‐P direction (three subjects anteriorly and two sub-

there is signiﬁcant difference between the dose to the PTV between

jects posteriorly). A signiﬁcant negative association between the

the full and empty bladder states. For change in bladder volumes, all

Superior–Inferior (S‐I) displacement of the prostate centroid with

of the associations with PTV dose measurements are positive and

respect to volume changes in the bladder as well as a positive asso-

signiﬁcant, except for maximum dose. Positive association indicates

ciation with respect to changes in the rectal volume was observed.

that dose to the PTV decreases as the bladder gets smaller. None of

In addition, in the A‐P direction, there was a strong positive associa-

the associations between the changes in rectum volume with PTV

tion between changes in the rectal volume and displacement of the

dose measurements were signiﬁcant. Similar ﬁndings were seen

prostate (P = 0.0001). The largest vector displacements were

when both the changes in bladder and rectum were included in the

observed in the SVs (range of 3.1 to 9.3 mm). SVs for all subjects

statistical models.
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F I G . 2 . Three‐dimensional representation
of the bladder (blue), rectum (red), prostate
(yellow), seminal vesicles (green) and
femoras/pubic bone (cyan) at three bladder
ﬁlling time points (TP) for subject 3 (S3)
and subject 7 (S7), who had the largest
prostate displacement between states. The
impact of bladder ﬁlling and rectal volume
on the position of the prostate and seminal
vesicles can be observed.
T A B L E 1 Centroid displacement of the prostate and seminal vesicles between initial and ﬁnal time points for the cohort. Δx, Δy, and Δz
represent displacement of the organ centroids in the LR, AP, and SI directions, respectively. The last two rows reﬂect the number of subjects
that had an organ center of mass displacement of >2 mm along each axis or as the total vector displacement.
Prostate

Average

SVs

Vector (mm)

Δx (mm)

3.55

−0.29

Δy (mm)

Δz (mm)

1.35

0.61

Vector (mm)

Δx (mm)

5.50

−0.24

Δy (mm)

Δz (mm)

2.21

1.28

Stdev

1.87

0.62

3.50

2.26

1.67

2.01

3.54

2.87

Min

1.27

−1.19

−5.81

−4.05

3.09

−3.01

−5.20

−5.43

Max

6.10

0.89

5.61

3.36

9.30

3.31

7.81

4.80

# of patients > 2 mm shift

6

0

3

3

9

2

7

4

# of patients < −2 mm shift

N/A

0

2

1

N/A

1

1

1

4 | DISCUSSION

planned bladder volume was greater than 200 ml. Also, when the
daily bladder volume was within the third quartiles of the planned

In this work, we did a systematic study of effects of bladder and rec-

CT volumes, the A‐P and S‐I intra‐fraction displacement of the pros-

tal volumes on displacement of the prostate and surrounding organs

tate was reduced.

as well as the impact of this displacement on the delivered dose to

The major contributor to vector displacements of the prostate

the PTV and (OARs). The bladder ﬁlling experiment was designed

and SVs is the change in bladder volume; however, rectal status/vol-

such that it made possible to model extreme ranges of the bladder

ume can also contribute to the range of displacements of these

volume and to observe the range of its effects.

organs, which can be dominant along different axes. This can be

Although previous studies seeking to ﬁnd an optimal bladder

observed in subject 7 (Fig. 2) where the displacement of the prostate

and rectal state30,31 for prostate radiotherapy have not found signif-

can be related to changes in the rectal volume. In this subject, the

icant differences in the intra‐fractional prostate displacement

rectal volume reduces in the second time point and increases in the

between plans that were designed for patients with full and empty

ﬁrst time point. Relative to the third time point, the prostate initially

bladders, they have not investigated displacement and change in the

moves posteriorly at the second time point and anteriorly at the ﬁrst

dose to the prostate between extreme bladder states. Our results

time point. This matches the results of our statistical analysis which

showed that changes in the bladder volume can lead to large, sys-

showed that the rectum volume is the main effector of displacement

tematic displacements in the prostate and SVs. The major displace-

of the prostate in the A‐P direction. It should be noted that in our

ments are observed in the A‐P and S‐I directions in both organs.

study, considering the change of rectal gas volume between differ-

While the prostate is shifted anteriorly in most cases as the bladder

ent measurements in some subjects, variations of susceptibility‐

volume is reduced, in some cases, posterior shift is observed. These

based distortions might affect the measured displacement of the

ﬁndings match the results of a recent study based on analysis of

organs near the rectum. However, previous measurements done

CBCT and four‐dimensional (4D) trans‐perineal ultrasound (4D

across three magnetic ﬁeld strengths (1.0, 1.5, and 3.0 T) showed

TPUS) measurements of 60 patients that showed intra‐fractional

that only 1.4% and 1.9% of all voxels in the Prostate and SVs were

motion of the prostate in the A‐P and S‐I directions.32 In this study,

distorted by greater than 0.5 mm33; therefore we do not expect the

reduction of A‐P motion of the prostate was observed when the

susceptibility‐based distortions to adversely impact our results.

NEJAD‐DAVARANI
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F I G . 3 . (Left) Synthetic computed
tomography (CT) images with dose
calculation results for the full and empty
bladder states of subjects 2 and 5, with
the initial plan optimized to the full bladder
geometry. (Right) Dose volume histograms
(DVHs) for the subjects at two bladder
states. A reduction in planning target
volume coverage can be observed due to
the shift of the prostate from the initial
planned location with changes in bladder
and rectal conditions. As expected,
increased bladder dose was also be
observed due to smaller bladder volumes.
This increase is more obvious in S5 where
the bladder dose exceeds the
recommended toxicity level.
A previously published CT‐based treatment planning study evalu-

change in the body coil placements were made during acquisition). By

ated the dosimetric impact of full and empty bladders.18 The present

conducting a within‐subject analysis, the impact of the table‐top selec-

study builds upon this previous work by incorporating MRI across 3–5

tion and body coils may be considered negligible within a particular

time points per subject. MRI has been shown to enable more accurate

subject. However, in clinical practice, acquiring MRI data in the treat-

and more consistent delineations.34 Further, Moiseenko et al. found that

ment position improves agreement between the anatomy at time of

bladder ﬁlling status had limited dosimetric impact on the prostate and

treatment planning and during treatment.34

rectal doses; however at that time, treatment planning was conducted
18

One limitation in the current work is that only nine healthy vol-

Our work implements much more

unteers were evaluated. Nevertheless, this yielded 34 overall sample

conformal treatment planning using arc therapy which showed that

points and enabled statistical comparisons to be made for both

when the bladder volume changes from full to empty, PTV coverage

geometry and dosimetry across the target and OARs. Another limita-

was adversely affected. Finally, while CT is the gold standard for treat-

tion of this work is that healthy volunteers were evaluated that may

ment planning, the present work is the ﬁrst to evaluate the performance

not be representative of the average prostate cancer population.

and dosimetric impact of synthetic CT across varied subject anatomies.

However, because this work included empty to very full bladder vol-

using a four‐ﬁeld box technique.

Previous studies have shown that using different table‐top conﬁg-

umes for each subject, we expect that the results, even at intermedi-

urations used in MRI (i.e., ﬂat and curved couches) may lead to

ate states, will extend to the prostate cancer population. Another

changes in the relative location of pelvic organs.35 When performing

limitation of this work is that because MR‐CATs were derived from

MRI scans with the patient in treatment position (i.e., using a ﬂat

healthy volunteers, no corresponding CTs were available for quanti-

tabletop similar to the treatment couch vs. a curved diagnostic couch),

tative MR‐CAT evaluation. However, a recent study illustrated a

more accurate rigid registrations between MR images and CT images

good agreement between MR‐CAT datasets and their corresponding

for prostate RT planning has been observed.36 It has also been shown

CTs with a low MAE in a patient cohort.12

that during MR‐SIM, the weight of the ﬂexible anterior body coils may

In the simulation that we performed, by evaluating the dose deliv-

contribute to changes in the position of pelvic organs.34 In this study,

ered to the organs at the bladder empty state using the treatment plan

serial imaging data were acquired using a single setup for each subject

optimized for the dose delivered to the PTV at the bladder full state, we

(i.e., subjects did not leave the MR table‐top during scanning and no

observed that reduction of the bladder size from the full state can lead
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T A B L E 2 Dose volume histogram (DVH) metrics for the planning target volume (PTV), bladder and rectum for the nine subjects. For each
subject, the top row represents the dose at the bladder empty state and the bottom row the dose at the bladder full state. Mean and standard
deviation of the dose in the initial and ﬁnal time points across all subjects has been calculated and the bottom row represents the signiﬁcance
of the difference between these doses in these two time points. Bold‐italized values indicate doses that are outside the accepted range.
PTV
Patient
S1

S2

S3

Status

Bladder

Rectum

Min D (Gy)

D95%(Gy)

D35%(Gy)

D25%(Gy)

D15%(Gy)

D35%(Gy)

D25%(Gy)

D15%(Gy)
80.53

Empty

14.6

66.9

53.4

61.2

72.5

55.3

68.60

Full

76.0

79.9

25.3

38.3

54.4

48.7

56.23

69.02

Empty

31.9

62.8

61.6

73.5

80.1

49.7

53.76

60.78

Full

73.2

78.8

40.6

51.3

65.5

51.0

57.75

69.05

Empty

50.3

69.7

60.4

67.1

75.7

40.9

49.78

63.89

Full

73.8

78.7

25.3

39.9

55.2

42.0

49.16

59.96

S4

Empty

28.4

68.9

36.7

49.8

67.8

38.0

43.61

59.13

Full

50.8

76.9

18.2

27.4

50.4

44.4

61.90

77.74

S5

Empty

47.3

72.1

76.8

80.3

81.3

38.9

50.48

73.63

Full

56.9

77.2

53.3

66.5

79.0

37.4

41.45

60.22

Empty

50.3

74.6

74.7

80.4

81.6

41.5

47.11

57.77

Full

69.5

77.6

47.9

51.0

72.8

46.9

55.38

69.33

Empty

30.3

62.9

34.2

44.4

61.1

44.5

54.50

64.03

Full

74.3

79.3

3.4

5.9

24.4

44.0

55.99

72.37

Empty

58.7

71.2

31.2

38.4

47.1

43.4

51.15

63.48

Full

74.1

79.0

4.1

9.1

32.3

37.1

46.22

56.26

S6

S7

S8

S9

Mean ± SD

P value

Empty

54.6

75.5

78.6

80.4

81.0

52.9

61.52

73.62

Full

72.9

78.7

30.8

41.5

57.1

53.9

63.06

74.48

Empty

11.8 ± 11.0

69.4 ± 4.3

56.4 ± 17.7

63.9 ± 15.5

72.0 ± 11.0

45.0 ± 5.9

53.39 ± 7.15

66.32 ± 7.33

Full

1.6 ± 1.2

78.5 ± 1.0

27.7 ± 17.6

36.8 ± 19.8

54.6 ± 17.6

45.0 ± 5.4

54.13 ± 6.75

67.60 ± 6.84

0.0003

0.002

<0.0001

<0.0001

<0.0001

0.9919

0.9158

0.9743

to decreased delivered doses to the PTV and increased dose to the
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bladder. Our study did not reveal any signiﬁcant change in the dose
delivered to the rectum. This simulation further revealed that due to the

Variations in the bladder volume can lead to the displacement of the

shift of the PTV, the dose to the bladder may exceed the maximum rec-

prostate which can negatively impact the dose delivered to the PTV

ommended dose to the bladder. Our results conﬁrm the results of

and the bladder. These results show the importance of proper prepa-

another study by Chen et al. which reported that increases in the blad-

ration of patients both for treatment and also during imaging ses-

der volume lead to reduction of the dose to the prostate.17 Using CBCT

sions, especially when imaging requires longer scan times such as

images of 19 subjects, they found that a 10% increase in bladder volume

MR protocols.

leads to 5.6% reduction of mean dose to the prostate. They did not ﬁnd
signiﬁcant variations of the rectal volume. These ﬁndings contradict a
previous report that although conﬁrming displacement of the prostate
in the A‐P direction after voiding the bladder, found no correlation
between prostate shifts with bladder and rectal volume.18 These results
may be due to that study only evaluating two bladder states (full and
empty), and imaging/contouring was done using CT images. Also, the
reference for prostate motion was based on external ﬁducial markers.
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